BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+18.89%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$26.5B
AUM Growth
+$26.5B
(+6.1%)
Cap. Flow
-$53.2M
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
84.24%
Holding
134
New
14
Increased
16
Reduced
60
Closed
7
Top Buys
| 1 |
AbCellera Biologics
ABCL
|
$421M |
| 2 |
Kodiak Sciences
KOD
|
$224M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$159M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$61.5M |
| 5 |
Aligos Therapeutics
ALGS
|
$44.5M |
Top Sells
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$422M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$410M |
| 3 |
Exact Sciences
EXAS
|
$188M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$20.2M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$19.7M |
Sector Composition
| 1 | Healthcare | 97.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOK
126
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| – | – |
-3,009,344
| Closed | -$410M |
|
|
UROV
127
DELISTED
Urovant Sciences Ltd.
UROV
| – | – |
-978,505
| Closed | -$9.14M |
|
|
ARAV
128
DELISTED
Aravive, Inc. Common Stock
ARAV
| – | – |
-75,854
| Closed | -$357K |
|
|
129
Exact Sciences
EXAS
$9.3B
| – | – |
-1,846,139
| Closed | -$188M |
|
130
Catalyst Pharmaceutical
CPRX
$2.44B
| – | – |
-474,400
| Closed | -$1.41M |
|
131
Applied Therapeutics
APLT
$72.7M
| – | – |
-38,034
| Closed | -$790K |
|